Manatuck Hill Partners’s CASI Pharmaceuticals CASI Stock Holding History

Manatuck Hill Partners’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,509	Closed	-$12K	–	97
2022 Q1	$12K	Buy	+1,509	New	+$11.9K	﹤0.01%	118
2021 Q4	–	Sell	-1,509	Closed	-$18K	–	106
2021 Q3	$18K	Hold	1,509	–	–	0.01%	116
2021 Q2	$23K	Buy	+1,509	New	+$25.4K	0.01%	133
2020 Q4	–	Sell	-1,509	Closed	-$23K	–	107
2020 Q3	$23K	Hold	1,509	–	–	0.01%	96
2020 Q2	$38K	Buy	+1,509	New	+$32.8K	0.02%	75
2018 Q4	–	Sell	-1,509	Closed	-$70K	–	96
2018 Q3	$70K	Hold	1,509	–	–	0.03%	83
2018 Q2	$124K	Buy	+1,509	New	+$102K	0.05%	91
2017 Q4	–	Sell	-1,509	Closed	-$27K	–	83
2017 Q3	$27K	Hold	1,509	–	–	0.01%	81
2017 Q2	$16K	Hold	1,509	–	–	0.01%	82
2017 Q1	$21K	Buy	+1,509	New	+$20.5K	0.01%	88
2016 Q4	–	Sell	-1,509	Closed	-$17K	–	87
2016 Q3	$17K	Hold	1,509	–	–	0.01%	93
2016 Q2	$18K	Hold	1,509	–	–	0.01%	88
2016 Q1	$16K	Buy	+1,509	New	+$14.6K	0.01%	85
2015 Q4	–	Sell	-1,509	Closed	-$16K	–	79
2015 Q3	$16K	Hold	1,509	–	–	0.01%	64
2015 Q2	$27K	Buy	+1,509	New	+$22.6K	0.01%	80
2014 Q4	–	Sell	-1,509	Closed	-$27K	–	82
2014 Q3	$27K	Buy	+1,509	New	+$26.8K	0.01%	103
2014 Q2	–	Sell	-1,509	Closed	-$27K	–	93
2014 Q1	$27K	Buy	+1,509	New	+$28.5K	﹤0.01%	106
2013 Q4	–	Sell	-1,509	Closed	-$27K	–	90
2013 Q3	$27K	Hold	1,509	–	–	﹤0.01%	96
2013 Q2	$30K	Buy	+1,509	New	+$29.3K	﹤0.01%	90

Other funds holding CASI

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Manatuck Hill Partners's CASI Position: Q2 2022 in Review

Manatuck Hill Partners sold out of CASI Pharmaceuticals (CASI) in Q2 2022, closing a stake of 1,509 shares — an estimated $12K sold.

Manatuck Hill Partners first reported a position in CASI in Q2 2013 and held it in 19 quarters. The position peaked at $124K in Q2 2018. 24 funds tracked by Wall St. Rank hold CASI as of Q2 2022.

Manatuck Hill Partners reported no remaining CASI Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Manatuck Hill Partners sold 1,509 CASI Pharmaceuticals shares in Q2 2022, an estimated $12K.
Manatuck Hill Partners first reported a position in CASI Pharmaceuticals in Q2 2013 and held it in 19 quarters.
Manatuck Hill Partners's CASI Pharmaceuticals position peaked at $124K in Q2 2018.
24 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2022.

Based on Manatuck Hill Partners's 13F filing for Q2 2022, filed 15 Aug 2022.